Suzuki, Kazuhito <br/><br/>
Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL.  [electronic resource] 

 -  Anti-cancer drugs  09 2016 
 - 756-65 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0000000000000389  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Azepines--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Down-Regulation--drug effects<br/>Gene Expression Regulation, Neoplastic<br/>Heterocyclic Compounds, 4 or More Rings--pharmacology<br/>Humans<br/>Molecular Targeted Therapy--methods<br/>Multiple Myeloma--drug therapy<br/>N-Myc Proto-Oncogene Protein--metabolism<br/>Protein Domains<br/>Proto-Oncogene Proteins c-myc--genetics<br/>Triazoles--pharmacology